For more information, please contact:
Edinburgh 3 April 2012 DySIS Medical Ltd, the medical devices company in female health, announces that the National Institute for Ghd Eclipse Review
Alastair Atkinson, CEO of DySIS Medical said: "Today's encouraging draft guidance from NICE coupled with an extremely positive response to our recent US launch are key milestones for the company.
"DySIS is a cost effective option for examining the uterine cervix in women referred for colposcopy and should be considered in procurement plans when replacing colposcopy equipment."
Johnson Johnson (JNJ) Hepatitis Ghd Sale C Drug Wins Backing From UK's National Institute for Clinical Excellence (NICE) Medtronic, Inc. (MDT) Pays $85 Million to End Shareholder Lawsuit
The introduction of cervical cancer screening in women over 25 has helped to reduce the incidence of the disease about 4.4 million women are screened in the UK each year even so, approximately, 900 women in England a year die of the disease and the cost to the healthcare services, including the NHS runs into multimillions. (BMET) Offers $280 Million for DePuy Orthopaedics, Inc. (JNJ) Trauma Business
DySIS colposcopy uses spectral imaging techniques during the course of a normal examination to highlight to clinicians any areas of concern by mapping the condition of a woman's cervix. In clinical trials, it has been shown to significantly boost sensitivity in detecting cervical cancer in its earliest stages. Armed with this additional information, clinicians are able to take immediate steps to treat patients and prevent disease progression.
National Institute for Beats By Dre Alexander Wang
Health and Clinical Excellence ('NICE') has today published draft guidance on its DySIS cervical cancer screening product for public consultation.
DySIS Medical Ltd has its global headquarters in Edinburgh. The company is committed to saving lives through the early detection and diagnosis of disease using biophotonic innovations. It aims to be the global leader in automated optical molecular imaging technologies for medical diagnostic and screening applications. The product is sold in Europe and the US.
Cervical cancer is the second most common cancer in women and accounts for more than one in ten (9%) of diagnosed female cancers. The World Health Organization estimates that there are over 500,000 new cases each year resulting in Ghd For Thick Hair
National Institute for Clinical Excellence (NICE) Backs Merck Co., Inc. (MRK) Hepatitis C Drug Victrelis Pentax Acquires Digital Endoscopy, Expanding Global R Capabilities
Clinical Excellence (NICE) Backs Novartis AG (NVS) MS Drug, Overturning Earlier Decision EasyMed to Merge With Canadian Device Maker Biosign Technologies Inc.
National Institute for Clinical Excellence NICE Publishes Positive Draft Guidance on DySIS Cervical Cancer Screenin
The NICE paper stated: "The Committee concluded that the modelling of DySIS colposcopy showed that it was robustly cost effective (possibly even cost saving) when compared with conventional colposcopy." Specifically the draft guidance stated, "The base case indicates that standard colposcopy was more expensive and less effective [than DySIS]."
Commenting on the announcement, Miss Theresa Freeman Wang, Consultant Gynaecologist MRCOG, Whittington Hospital, who has been using DySIS, said "The extra sensitivity that DySIS delivers could be very helpful in detecting the smaller pre cancerous lesions that require treatment and may assist in safely reducing the need for Colposcopy follow up appointments."
National Institute for Clinical Excellence (NICE) Backs Earlier Use of Roche (RHHBY)'s Arthritis Therapy RoActemra Fenwal Receives FDA Clearance for Therapeutic Plasma Exchange on Its Amicus Separator
250,000 deaths. In the developed world, where screening programmes are used, some 30 million women will receive an abnormal smear test result and be called for a colposcopy examination. If caught and treated at an early stage, there is a high degree of treatment success.
The report also noted: "The sensitivity of DySIS remained high (77.4%) in the subgroup of women referred to colposcopy with low grade cytology, whereas the sensitivity of conventional colposcopy was low (19.4%)." A higher sensitivity in detecting cervical changes as early as possible implies a reduced cost burden to healthcare systems.
Adidas Football Boots Sale
Adidas Football Shoes New 2017
Ghd Straighteners 1v
Puma Evopower Pink And Blue Futsal
Babyliss Straightener And Curler
Beats By Dre Studio Wireless Matte Black
Ghd Hair Dryer And Straighteners Gift Set
Beats Monster Studio Wireless
Beats By Dre Tour 2
Ghd Straighteners Ebay
Adidas Predator Instinct White
New Ghd Hair Straightener
Beats By Dre Apple
Puma Football Boots Red
Ghd Jewel Collection